My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Corcept Therapeutics Incorporated - Common Stock
(NQ:
CORT
)
73.96
-14.40 (-16.30%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 10, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Corcept Therapeutics Incorporated - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
CORCEPT THERAPEUTICS ANNOUNCES FIRST QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
May 05, 2025
From
Corcept Therapeutics
Via
Business Wire
Earnings Scheduled For May 5, 2025
May 05, 2025
Via
Benzinga
Corcept (CORT) To Report Earnings Tomorrow: Here Is What To Expect
May 04, 2025
Biopharma company Corcept Therapeutics (NASDAQ:CORT) will be reporting earnings tomorrow after the bell. Here’s what to expect.
Via
StockStory
Topics
Artificial Intelligence
CORCEPT THERAPEUTICS INC (NASDAQ:CORT), a strong growth stock, setting up for a breakout.
April 30, 2025
Based on a technical and fundamental analysis of NASDAQ:CORT we ask: Is CORCEPT THERAPEUTICS INC (NASDAQ:CORT) on the Verge of a Major Breakout as a Strong Growth Stock?
Via
Chartmill
CORCEPT THERAPEUTICS TO ANNOUNCE FIRST QUARTER FINANCIAL RESULTS, PROVIDE CORPORATE UPDATE AND HOST CONFERENCE CALL
April 28, 2025
From
Corcept Therapeutics Incorporated
Via
Business Wire
3 Healthcare Stocks That Concern Us
April 28, 2025
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Despite the rosy long-term prospects, short-term headwinds such as COVID...
Via
StockStory
Topics
Stocks
Here's How Much $1000 Invested In Corcept Therapeutics 10 Years Ago Would Be Worth Today
April 25, 2025
Via
Benzinga
CORCEPT TO PRESENT LATE-BREAKING DATA FROM PIVOTAL PHASE 3 ROSELLA TRIAL OF RELACORILANT IN PLATINUM-RESISTANT OVARIAN CANCER AT ASCO 2025
April 23, 2025
From
Corcept Therapeutics Incorporated
Via
Business Wire
Diabetes Care Publishes Results From Prevalence Phase Of Corcept’s CATALYST Trial In People With Difficult-To-Control Type 2 Diabetes
April 21, 2025
From
Corcept Therapeutics Incorporated
Via
Business Wire
SoundHound AI, Domo, Plug Power, Corcept, and 8x8 Shares Are Falling, What You Need To Know
April 16, 2025
A number of stocks fell in the afternoon session after Federal Reserve Chair Jerome Powell signaled a cautious stance on future monetary policy decisions during a speech in Chicago, emphasizing that...
Via
StockStory
Topics
Artificial Intelligence
Economy
Government
$1000 Invested In Corcept Therapeutics 20 Years Ago Would Be Worth This Much Today
April 16, 2025
Via
Benzinga
Investors seeking growth at a reasonable cost should explore CORCEPT THERAPEUTICS INC (NASDAQ:CORT).
April 15, 2025
NASDAQ:CORT is scoring great on several growth aspects while it also shows decent health and profitability. At the same time it remains remains attractively priced.
Via
Chartmill
3 Biopharmaceutical Stocks Bucking the Sell-Off
April 10, 2025
Three biopharma companies may appeal to investors looking for firms that have not been rocked by tariff-inspired turbulence.
Via
MarketBeat
Topics
World Trade
Q4 Earnings Highs And Lows: Eli Lilly (NYSE:LLY) Vs The Rest Of The Branded Pharmaceuticals Stocks
April 10, 2025
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Eli Lilly (NYSE:LLY) and its peers.
Via
StockStory
Topics
Artificial Intelligence
Intellectual Property
Q4 Earnings Roundup: Organon (NYSE:OGN) And The Rest Of The Branded Pharmaceuticals Segment
April 08, 2025
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Organon (NYSE:OGN) and the best and worst...
Via
StockStory
Topics
Artificial Intelligence
Intellectual Property
Corcept Initiates Trial of Relacorilant Plus Nab-Paclitaxel and Bevacizumab in Patients With Platinum-Resistant Ovarian Cancer
April 07, 2025
From
Corcept Therapeutics Incorporated
Via
Business Wire
How Some Mid Cap Stocks Outshone The S&P 400's Dramatic Drop Last Week (Mar 31-Apr 4)
April 06, 2025
Mid-cap stocks surged in the past week, including CORT, COOP, and CRWV. GOOG may rent AI servers from CRWV. PRGS and LOAR reported strong results.
Via
Benzinga
Topics
Artificial Intelligence
Stocks
12 Health Care Stocks Moving In Tuesday's Intraday Session
April 01, 2025
Via
Benzinga
Top stock movements in today's session.
March 31, 2025
Keep an eye on the top gainers and losers in Monday's session, as they reflect the most notable price movements.
Via
Chartmill
Deep Dive Into Corcept Therapeutics Stock: Analyst Perspectives (7 Ratings)
March 31, 2025
Via
Benzinga
Corcept Therapeutics Stock Jumps On Upbeat Ovarian Cancer Trial Data, Analysts Boost Price Forecast
March 31, 2025
Corcept's ROSELLA trial met its primary endpoint, showing relacorilant improved progression-free and overall survival in platinum-resistant ovarian cancer.
Via
Benzinga
Why Is Corcept (CORT) Stock Soaring Today
March 31, 2025
Shares of biopharma company Corcept Therapeutics (NASDAQ:CORT) jumped 94.9% in the afternoon session after the company announced that its Phase 3 trial (ROSELLA) met its goal of improving...
Via
StockStory
Topics
Artificial Intelligence
Monday's session: top gainers and losers
March 31, 2025
Wondering how the US markets performed in the middle of the day on Monday? Discover the movers and shakers of today's session in our comprehensive analysis.
Via
Chartmill
12 Health Care Stocks Moving In Monday's Intraday Session
March 31, 2025
Via
Benzinga
These stocks are gapping in today's session
March 31, 2025
Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Monday. Let's explore the market movements and identify the stocks with significant gaps.
Via
Chartmill
Dow Gains Over 100 Points; NewGenIvf Group Shares Plummet
March 31, 2025
Via
Benzinga
Topics
Stocks
Mr. Cooper Group, Southern States Bancshares, Corcept Therapeutics And Other Big Stocks Moving Higher On Monday
March 31, 2025
Via
Benzinga
Monday's pre-market session: top gainers and losers
March 31, 2025
Wondering what's happening in Monday's pre-market session? Find an overview in this article.
Via
Chartmill
Nasdaq Tumbles Over 300 Points; Chicago PMI Rises In March
March 31, 2025
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
March 31, 2025
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.